To describe the case of a patient with a large macular hole formation after pars plana vitrectomy for a diabetic tractional retinal detachment who was successfully treated with plasma rich in growth factors (PRGF) membrane.
Setting/Venue
The patient was first attended in February of 2018 in Hospital Virgen de La Victoria, Málaga, Spain.
Methods
We describe a case of a 27-year-old patient operated via pars plana vitrectomy (PPV) and silicone tamponade for a diabetic tractional retinal detachment, achieving a best corrected visual acuity (BCVA) of 0.3. Three months after the extraction of silicone, a large macular hole was observed and the BCVA decreased to hand movement (HM). A new PPV was carried out with the placement of an autologous PRGF membrane and a 20 % sulfur hexafluoride tamponade.
Results
At 8 weeks follow up appointment we observed a complete closure of the macular hole and an improvement of BCVA to 0.05. No adverse effects were associated with the use of the PRGF membrane in the follow up period of the patient.
Conlusions
The PRGF-membrane is a adjunctive therapy for the management of large or recurrent macular holes. In our patient we achieved complete closure of the macular hole and a visual improvement with no adverse reactions associated.
Financial Disclosure
The authors report no conflicts of interest in this work